GEXVal CEO Invited to Speak at "Australia-Japan Innovation Alliance Forum 2026"
wpmaster
株式会社GEXVal
September 18, 2026
GEXVal CEO Invited to Speak at "Australia-Japan Innovation Alliance Forum 2026"
GEXVal Inc. (President & CEO/Chief Scientific Officer: Juran Kato, PhD; Headquarters: Fujisawa, Kanagawa, Japan; hereinafter “GEXVal”) is pleased to announce that Dr. Juran Kato has been invited to speak as a panelist on the "Panel Discussion 1: From Discovery to Start-up: Innovation Precinct Experiences" session at "Australia-Japan Innovation Alliance Forum 2026," held on October 2, 2026 (Fri) at Kashiwa-no-ha Conference Center in Kashiwa, Chiba Prefecture, and hosted by the Australia-Japan Business Co-operation Committee (AJBCC).
[Event Overview]
This forum is an annual event hosted by AJBCC to promote innovation collaboration between Japan and Australia, now in its fifth year. It will be held in Kashiwa-no-ha Smart City, known as an innovation hub built on industry-academia-government collaboration, under the theme "Cross Border & Sector Collaboration to Commercialise Innovation," taking place immediately ahead of the 63rd Annual Australia-Japan Joint Business Conference, held October 4-6, 2026, at Makuhari Messe in Chiba Prefecture.
**Event Details**
|
Event Name |
Australia-Japan Innovation Alliance Forum 2026 |
|
Date & Time |
Friday, October 2, 2026, 9:30 AM – 4:00 PM Presentation: Friday, October 2, 2026, 2:00 PM – 3:00 PM |
|
Venue |
Kashiwa-no-ha Conference Center |
|
Title |
Panel Discussion 1, "From Discovery to Start-up: Innovation Precinct Experiences" |
|
Details & Registration |
[CEO Comment]
Public-private partnership has grown increasingly important in recent years, and Kashiwa-no-ha embodies a rare model where industry, academia, and government work together to carry innovation all the way to social implementation. GEXVal has already conducted and completed a Phase 1 clinical trial in Australia, making collaboration between Japan and Australia a theme grounded in our own track record. I am honored to have this opportunity to discuss innovation creation from both Japanese and Australian perspectives.
[About GEXVal]
GEXVal strives to create and develop innovative pharmaceuticals for unmet medical needs, ensuring Treatment Reaching the Unreached with focus on rare diseases and underserved medical conditions. By leveraging our proprietary AI-powered pharmacoinformatics technology, we illuminate paths to breakthrough therapies, identifying hidden potential in drug candidates to deliver life-changing medicines that bring new hope to patients and their families.
有关本事宜请咨询:
Head of Corporate Office
Atsushi Sugizaki
info@gexval.com
